At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Homocysteine and Progression of Atherosclerosis
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Feb 18, 2016
In Brief
An observational study for Cardiovascular Diseases and 6 related conditions. Completed.
Detailed Summary
In the first phase, to establish the relationship of progression of peripheral vascular disease (PVD) to plasma homocysteine. In the second phase, to conduct a randomized, controlled trial of folic acid treatment of plasma homocysteine in peripheral vascular disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Peripheral Vascular Diseases, Atherosclerosis, Cerebrovascular Disorders, Myocardial Infarction, Heart Diseases, Hyperhomocysteinemia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 1991
First PostedMay 2000
Study CompletionAug 2004
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartAug 1, 1991
Study CompletionAug 1, 2004
TodayJul 2, 2026
Posted 26.1 years ago